The expression of PTGS2 was independently associated with ACTA2 in non-cancerous tissue, explaining 38% in gene variability, and BCL2 was independently associated with ACTA2 in gastric tumors, explaining 39% in gene variability. This evidence concerns the gene PTGS2 and gastric neoplasm.